NOT FOR DISTRIBUTION TO U.S NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESMONTREAL, June 16, 2025 (GLOBE NEWSWIRE) -- Opus One Gold Corp (TSX-V: OOR) (the “Company” or “Opus One”) is pleased to announce that drill hole NO-25-14 from the winter drilling program on its 100% owned Noyell project near the town of Matagami, Abitibi, Québec, Canada, returned 8.96g/t Au over 5.2 m from 165 to 170.2 m. The mineralized interval represents a true width of approximately 4.2 m within the Zone 1 structure. ...

BOSTON and LONDON, June 16, 2025 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has cleared the IND to initiate a Phase 1 clinical study of ORX142 in healthy volunteers. ORX142 is an investigational, novel, highly potent and selective OX2R agonist being developed for the treatment of select neurological and neurodegenerative disorders. ORX142 is the second drug candidate from the Compa ...

NORTH CHICAGO, Ill., June 16, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced the global Phase 3 VERONA trial evaluating venetoclax in combination with azacitidine in the treatment of newly diagnosed higher-risk myelodysplastic syndrome (HR-MDS) did not meet the primary endpoint of overall survival (OS) with a hazard ratio (HR) of 0.908; stratified log-rank, p=0.3772. No new safety signals were observed.1 Results from the VERONA trial will be available in a future medical congress and/or publication. Any ...

VANCOUVER, British Columbia, June 16, 2025 (GLOBE NEWSWIRE) -- Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost” or the “Company”) is pleased today to announce a significant strengthening of its financial position and the continuation of its strategic national marketing initiative. As a result of recent exercises of warrants and options by warrant holders and insiders, the treasury has been bolstered by over $4.5 million. This substantial increase in capital provides a solid foundation for Fo ...

Home Run! Adia Med of Winter Park's AHCA Triumph Brings Insurance-Covered Healing to PatientsJune 16, 2025 9:00 AM EDT | Source: Adia Nutrition Inc.Winter Park, Florida--(Newsfile Corp. - June 16, 2025) - Adia Nutrition, Inc. (OTCQB: ADIA), a leading innovator in regenerative medicine and nutritional supplements, is thrilled to announce that its state-of-the-art clinic, Adia Med of Winter Park, has received full approval from the Agency for Health Care Administration (AHCA). This milestone all ...

COLUMBIA, Md., June 16, 2025 (GLOBE NEWSWIRE) -- Tenable®, the exposure management company, today announced that Tenable Vulnerability Management has been recognized with a prestigious 2025 Globee® Award for AI-Powered Vulnerability Management. This latest accolade underscores Tenable's market leadership, delivering advanced exposure management solutions that revolutionize the way organizations identify, prioritize and remediate cyber risk. “This achievement is a testament to Tenable's commitment to innovat ...

BURLINGTON, Mass., June 16, 2025 (GLOBE NEWSWIRE) -- Progress Software (Nasdaq: PRGS), the trusted provider of AI-powered digital experience and infrastructure software, today announced that it will release financial results for its fiscal second quarter of 2025 after the market close on Monday, June 30, 2025. Progress will host a conference call to review and discuss the results at 5:00 p.m. ET the same day. The company’s second quarter of fiscal year 2025 ended on May 31, 2025. Conference Call DetailsA li ...

STORM-PE is a first-of-its-kind clinical trial comparing computer assisted vacuum thrombectomy (CAVT™) using Penumbra's Lightning Flash™ with anticoagulation versus anticoagulation alone in the treatment of acute intermediate-high risk pulmonary embolismALAMEDA, Calif., June 16, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced the completion of enrollment in the STORM-PE clinical trial. The pivotal, prospective, multi-center randomized controlled trial enr ...

On 16 June, 2025 the Supervisory Board of ŽEMAITIJOS PIENAS, AB (hereinafter – the Company) adopted the decision to recall Algirdas Pažemeckas from the Board of the Company from the end of the meeting of the Board of Supervisors of the Company that recalled her. The Company will notify of the actions regarding a new member of the Company‘s Board election in accordance with the procedure prescribed by legislation. The person authorized to provide additional information: Head of LegalArnas MatuzasE-mail: a.m ...

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. This article is intended to provide informational content and should not be viewed as an exhaustive an ...